Ryan Nipp to Retrospective Studies
This is a "connection" page, showing publications Ryan Nipp has written about Retrospective Studies.
Connection Strength
0.517
-
Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment. Pancreas. 2017 02; 46(2):183-189.
Score: 0.087
-
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology. Oncologist. 2022 Sep 02; 27(9):778-789.
Score: 0.032
-
The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm. PLoS One. 2022; 17(4):e0265767.
Score: 0.031
-
End-of-Life Care for Older Adults with Aggressive Non-Hodgkin Lymphoma. J Palliat Med. 2022 05; 25(5):728-733.
Score: 0.030
-
Clinical Outcomes, Treatment Toxicity, and Health Care Utilization in Older Adults with Aggressive Non-Hodgkin Lymphoma. Oncologist. 2021 11; 26(11):965-973.
Score: 0.030
-
Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss. Oncologist. 2021 06; 26(6):e963-e970.
Score: 0.029
-
Video-Based Telehealth Visits Decrease With Increasing Age. Am J Gastroenterol. 2021 02 01; 116(2):431-432.
Score: 0.029
-
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin. Oncologist. 2021 04; 26(4):325-331.
Score: 0.029
-
What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy. J Natl Compr Canc Netw. 2020 06; 18(6):676-681.
Score: 0.028
-
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors. Cancer. 2020 05 15; 126(10):2288-2295.
Score: 0.027
-
Potentially burdensome end-of-life transitions among nursing home residents with poor-prognosis cancer. Cancer. 2020 03 15; 126(6):1322-1329.
Score: 0.027
-
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Ann Surg. 2019 04; 269(4):733-740.
Score: 0.025
-
Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 03; 14(3):547-552.
Score: 0.025
-
Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2018 07; 41(7):656-661.
Score: 0.024
-
Hospice utilization in patients with malignant gliomas. Neuro Oncol. 2018 03 27; 20(4):538-545.
Score: 0.024
-
Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer. Dis Colon Rectum. 2016 Mar; 59(3):187-93.
Score: 0.021
-
Symptom Burden and Performance Status among Community-Dwelling Patients with Serious Illness. J Palliat Med. 2015 Jun; 18(6):542-4.
Score: 0.019